Dr. Fradet is co-founder of the Company and Chairman of the Board of Directors of DiagnoCure. He graduated from Medical School at Université Laval in 1976 and is member of the Royal College of Physicians and Surgeons of Canada since 1981. He has been full professor of surgery/urology at Université Laval since 1992. He is also Director, Urology Services, and Director of the Experimental Uro-Oncology Laboratory at the CHUQ - Hôtel-Dieu de Québec. Dr. Fradet studied at the Memorial Sloan-Kettering Cancer Center in New York from 1981 to 1983, where he sub-specialized in urologic oncology. He is a member of several national and international associations and was the first Canadian member of the Urology Research Society. This society is limited to 100 members from all around the world admitted by invitation from the most recognized researchers in urology. He serves as consultant for numerous national and international organizations and he is a frequent invited speaker around the world. He was the founding President of the Canadian Urological Oncology Group, which conducts clinical trials in the field of genito-urinary cancers in Canada. He has published over 180 articles and more than 300 abstracts. Dr. Fradet was appointed Chairman of the Board in January 2010 and President of DiagnoCure in February 2010.

Mrs. Miklosi brings over 15 years experience in investment banking and finance. She holds a BBA in finance from HEC Montreal (1993) and a MBA from the University of Western Ontario, Ivey School of Business (1998). Mrs. Miklosi spent five years as an investment banker at Thomas Weisel Partners, Montgomery Securities and Nesbitt Burns. She then served as Senior Director of Financial Planning and Analysis at Versata (2000-2003), a publicly traded software company, where-in addition to overseeing finance functions she was responsible for investor relations and sales operations. At Orrick, Herrington & Sutcliffe LLP (2003-2004), a national U.S. law firm, she was a Senior Finance Executive responsible for financial statement analysis, budgeting, treasury and M&A. She then spent four years as Managing Director and Chief Financial Officer at JMP Securities in San Francisco (2004-2008), a publicly traded investment bank and asset management firm, where she was responsible for the firm's accounting and financial operations. During her tenure at JMP, the firm successfully completed its initial public offering converting from a partnership to a C-Corporation and implemented Sarbanes Oxley within budget and timeline. Mrs. Miklosi joined DiagnoCure in July 2010 as Chief Financial Officer. 

Frédéric Boivin holds a Bachelor's Degree in Business Administration from Université Laval since 1996. From 1996 to 2001, he was controller at four private companies managed by the same shareholder. Mr. Boivin joined DiagnoCure in March 2001 as Coordinator, Finance & Administration. On November 2003, Mr. Boivin was appointed as Director, Finance & Administration. He is currently Senior Director, Finance & Administration.